Sitemap
June 05, 2016 Articles
Filter by Available Specialty
- Bone Solutions Inc receives $1.7 million in funding
- Chemoradiation improves OS, PFS in older patients with glioblastoma
- CPX-351 improves survival for older patients with high-risk secondary AML
- Daratumumab combination improves PFS, ORR in relapsed, refractory multiple myeloma
- DFS can serve as surrogate for OS in localized prostate cancer
- Extended hormone therapy prolongs DFS, maintains quality of life
- Extended lymph node dissection may improve survival for patients with bladder cancer
- Five most-viewed retina stories from ARVO
- Higher, split doses may reduce toxicity of CTL019 in adult ALL
- Increased BMI at age 13 years linked with colon cancer risk in adulthood
- NIH launches $9 million program to train workers on infectious disease safety
- Nivolumab demonstrates encouraging activity in metastatic colorectal cancer
- Sentinel node biopsy noninferior to axillary lymph node dissection for node-positive breast cancer
- Tandem therapy improves outcomes for children with neuroblastoma
- VIDEO: Combination therapies may improve response to checkpoint inhibitors
- VIDEO: Expert presents results from RESPOND study of TAVR system